AAAAAA

   
Results: 1-20 |
Results: 20

Authors: SOESMAN NMR RIMMELZWAAN GF METSELAAR HJ KEMMEREN MH OSTERHAUS ADME DEMAN RA
Citation: Nmr. Soesman et al., EFFICACY OF INFLUENZA VACCINATION IN LIVER-TRANSPLANT RECIPIENTS IN COMPARISON TO LIVER-CIRRHOSIS PATIENTS AND HEALTHY CONTROLS, Hepatology, 28(4), 1998, pp. 2301-2301

Authors: KROON FP RIMMELZWAAN GF ROOS MTL OSTERHAUS AME HAMANN D MIEDEMA F VANDISSEL JT
Citation: Fp. Kroon et al., RESTORED HUMORAL IMMUNE-RESPONSE TO INFLUENZA VACCINATION IN HIV-INFECTED ADULTS TREATED WITH HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY, AIDS, 12(17), 1998, pp. 217-223

Authors: CLAAS ECJ DEJONG JC VANBEEK R RIMMELZWAAN GF OSTERHAUS ADME
Citation: Ecj. Claas et al., HUMAN INFLUENZA-VIRUS A HONGKONG/156/97 (H5N1) INFECTION/, Vaccine, 16(9-10), 1998, pp. 977-978

Authors: HUISMAN W KARLAS JA SIEBELINK KHJ HUISMAN RC DERONDE A FRANCIS MJ RIMMELZWAAN GF OSTERHAUS ADME
Citation: W. Huisman et al., FELINE IMMUNODEFICIENCY VIRUS SUBUNIT VACCINES THAT INDUCE VIRUS NEUTRALIZING ANTIBODIES BUT NO PROTECTION AGAINST CHALLENGE INFECTION, Vaccine, 16(2-3), 1998, pp. 181-187

Authors: RIMMELZWAAN GF BAARS M CLAAS ECJ OSTERHAUS ADME
Citation: Gf. Rimmelzwaan et al., COMPARISON OF RNA HYBRIDIZATION, HEMAGGLUTINATION ASSAY, TITRATION OFINFECTIOUS VIRUS AND IMMUNOFLUORESCENCE AS METHODS FOR MONITORING INFLUENZA-VIRUS REPLICATION IN-VITRO, Journal of virological methods, 74(1), 1998, pp. 57-66

Authors: KARLAS JA SIEBELINK KHJ VANPEER MA HUISMAN W RIMMELZWAAN GF OSTERHAUS ADME
Citation: Ja. Karlas et al., ACCELERATED VIREMIA IN CATS VACCINATED WITH FIXED AUTOLOGOUS FIV-INFECTED CELLS, Veterinary immunology and immunopathology, 65(2-4), 1998, pp. 353-365

Authors: CLAAS ECJ OSTERHAUS ADME VANBEEK R DEJONG JC RIMMELZWAAN GF SENNE DA KRAUSS S SHORTRIDGE KF WEBSTER RG
Citation: Ecj. Claas et al., HUMAN INFLUENZA-A H5N1 VIRUS-RELATED TO A HIGHLY PATHOGENIC AVIAN INFLUENZA-VIRUS, Lancet, 351(9101), 1998, pp. 472-477

Authors: VOETEN JTM GROEN J VANALPHEN D CLAAS ECJ DEGROOT R OSTERHAUS ADME RIMMELZWAAN GF
Citation: Jtm. Voeten et al., USE OF RECOMBINANT NUCLEOPROTEINS IN ENZYME-LINKED IMMUNOSORBENT ASSAYS FOR DETECTION OF VIRUS-SPECIFIC IMMUNOGLOBULIN-A (IGA) AND IGG ANTIBODIES IN INFLUENZA-VIRUS-A-INFECTED OR INFLUENZA-VIRUS-B-INFECTED PATIENTS, Journal of clinical microbiology (Print), 36(12), 1998, pp. 3527-3531

Authors: SCHUTTEN M ANDEWEG AC RIMMELZWAAN GF OSTERHAUS ADME
Citation: M. Schutten et al., MODULATION OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN-MEDIATED ENTRY BY HUMAN-ANTIBODIES, Journal of General Virology, 78, 1997, pp. 999-1006

Authors: RIMMELZWAAN GF BAARS M VANBEEK R VANAMERONGEN G LOVGRENBENGTSSON K CLAAS ECJ OSTERHAUS ADME
Citation: Gf. Rimmelzwaan et al., INDUCTION OF PROTECTIVE IMMUNITY AGAINST INFLUENZA-VIRUS IN A MACAQUEMODEL - COMPARISON OF CONVENTIONAL AND ISCOM VACCINES, Journal of General Virology, 78, 1997, pp. 757-765

Authors: OSTERHAUS ADME TIJHAAR E HUISMAN RC HUISMAN W DARBY IH FRANCIS MJ RIMMELZWAAN GF SIEBELINK KHJ
Citation: Adme. Osterhaus et al., ACCELERATED VIREMIA IN CATS VACCINATED WITH RECOMBINANT VACCINIA VIRUS EXPRESSING ENVELOPE GLYCOPROTEIN OF FELINE IMMUNODEFICIENCY VIRUS, AIDS research and human retroviruses, 12(5), 1996, pp. 437-441

Authors: RIMMELZWAAN GF OSTERHAUS ADME
Citation: Gf. Rimmelzwaan et Adme. Osterhaus, CYTOTOXIC T-LYMPHOCYTE MEMORY - ROLE IN CROSS-PROTECTIVE IMMUNITY AGAINST INFLUENZA, Vaccine, 13(8), 1995, pp. 703-705

Authors: HULSKOTTE EGJ RIMMELZWAAN GF BOES J BOSCH ML HEENEY JL NORLEY SG DEVRIES P OSTERHAUS ADME
Citation: Egj. Hulskotte et al., ANTIGENICITY AND IMMUNOGENICITY OF RECOMBINANT ENVELOPE GLYCOPROTEINSOF SIVMAC32H WITH DIFFERENT IN-VIVO PASSAGE HISTORIES, Vaccine, 13(13), 1995, pp. 1187-1197

Authors: SIEBELINK KHJ BOSCH ML RIMMELZWAAN GF MELOEN RH OSTERHAUS ADME
Citation: Khj. Siebelink et al., 2 DIFFERENT MUTATIONS IN THE ENVELOPE PROTEIN OF FELINE IMMUNODEFICIENCY VIRUS ALLOW THE VIRUS TO ESCAPE FROM NEUTRALIZATION BY FELINE SERUM ANTIBODIES, Veterinary immunology and immunopathology, 46(1-2), 1995, pp. 51-59

Authors: SIEBELINK KHJ KARLAS JA RIMMELZWAAN GF OSTERHAUS ADME BOSCH ML
Citation: Khj. Siebelink et al., A DETERMINANT OF FELINE IMMUNODEFICIENCY VIRUS INVOLVED IN CRANDELL FELINE KIDNEY-CELL TROPISM, Veterinary immunology and immunopathology, 46(1-2), 1995, pp. 61-69

Authors: CLAAS ECJ DEJONG JC BARTELDS AIM BIJLSMA K ROTHBARTH P DEGROOT R RIMMELZWAAN GF OSTERHAUS ADME
Citation: Ecj. Claas et al., INFLUENZA TYPES AND PATIENT POPULATION, Lancet, 346(8968), 1995, pp. 180-180

Authors: SIEBELINK KHJ HUISMAN W KARLAS JA RIMMELZWAAN GF BOSCH ML OSTERHAUS ADME
Citation: Khj. Siebelink et al., NEUTRALIZATION OF FELINE IMMUNODEFICIENCY VIRUS BY POLYCLONAL FELINE ANTIBODY - SIMULTANEOUS INVOLVEMENT OF HYPERVARIABLE REGION-4 AND REGION-5 OF THE SURFACE GLYCOPROTEIN, Journal of virology, 69(8), 1995, pp. 5124-5127

Authors: SIEBELINK KHJ TIJHAAR E HUISMAN RC HUISMAN W DERONDE A DARBY IH FRANCIS MJ RIMMELZWAAN GF OSTERHAUS ADME
Citation: Khj. Siebelink et al., ENHANCEMENT OF FELINE IMMUNODEFICIENCY VIRUS-INFECTION AFTER IMMUNIZATION WITH ENVELOPE GLYCOPROTEIN SUBUNIT VACCINES, Journal of virology, 69(6), 1995, pp. 3704-3711

Authors: RIMMELZWAAN GF SIEBELINK KHJ BROOS H DROST GA WEIJER K VANHERWIJNEN R OSTERHAUS ADME
Citation: Gf. Rimmelzwaan et al., GAG-SPECIFIC AND ENV-SPECIFIC SERUM ANTIBODIES IN CATS AFTER NATURAL AND EXPERIMENTAL-INFECTION WITH FELINE IMMUNODEFICIENCY VIRUS, Veterinary microbiology, 39(1-2), 1994, pp. 153-165

Authors: RIMMELZWAAN GF SIEBELINK KHJ HUISMAN RC MOSS B FRANCIS MJ OSTERHAUS ADME
Citation: Gf. Rimmelzwaan et al., REMOVAL OF THE CLEAVAGE SITE OF RECOMBINANT FELINE IMMUNODEFICIENCY VIRUS ENVELOPE PROTEIN FACILITATES INCORPORATION OF THE SURFACE GLYCOPROTEIN IN IMMUNE-STIMULATING COMPLEXES, Journal of General Virology, 75, 1994, pp. 2097-2102
Risultati: 1-20 |